Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Optimization of [(11)C]raclopride positron emission tomographic rat studies: comparison of methods for image quantification.

Torrent E, Farré M, Abasolo I, Millan O, Llop J, Gispert JD, Ruiz A, Pareto D.

Mol Imaging. 2013 Jun;12(4):257-62.

PMID:
23651503
2.

Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.

Patel VD, Lee DE, Alexoff DL, Dewey SL, Schiffer WK.

Neuroimage. 2008 Jul 1;41(3):1051-66. doi: 10.1016/j.neuroimage.2008.02.065. Epub 2008 Mar 19.

PMID:
18442926
3.

Evaluation of analytical reconstruction with a new gap-filling method in comparison to iterative reconstruction in [¹¹C]-raclopride PET studies.

Tuna U, Johansson J, Ruotsalainen U.

Ann Nucl Med. 2014 Jun;28(5):417-29. doi: 10.1007/s12149-014-0832-y. Epub 2014 Mar 20.

PMID:
24647993
4.

Image segmentation and activity estimation for microPET 11C-raclopride images using an expectation-maximum algorithm with a mixture of Poisson distributions.

Su KH, Chen JS, Lee JS, Hu CM, Chang CW, Chou YH, Liu RS, Chen JC.

Comput Med Imaging Graph. 2011 Jul;35(5):417-26. doi: 10.1016/j.compmedimag.2011.01.004. Epub 2011 Feb 1.

PMID:
21288690
5.

Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.

McCormick PN, Kapur S, Reckless G, Wilson AA.

Synapse. 2009 Nov;63(11):998-1009. doi: 10.1002/syn.20671.

PMID:
19598174
6.
7.

Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET.

Hume SP, Opacka-Juffry J, Myers R, Ahier RG, Ashworth S, Brooks DJ, Lammertsma AA.

Synapse. 1995 Sep;21(1):45-53.

PMID:
8525461
8.

Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine.

Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, Benkelfat C.

J Neurosci. 2007 Apr 11;27(15):3998-4003.

9.

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.

Synapse. 2004 Jun 1;52(3):188-208.

PMID:
15065219
10.

Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity.

Alexoff DL, Vaska P, Marsteller D, Gerasimov T, Li J, Logan J, Fowler JS, Taintor NB, Thanos PK, Volkow ND.

J Nucl Med. 2003 May;44(5):815-22.

11.

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F.

Psychopharmacology (Berl). 2000 Jul;150(4):422-9.

PMID:
10958084
12.
13.

Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity.

Fujimura Y, Ito H, Takahashi H, Yasuno F, Ikoma Y, Zhang MR, Nanko S, Suzuki K, Suhara T.

Nucl Med Biol. 2010 Oct;37(7):831-5. doi: 10.1016/j.nucmedbio.2010.04.138.

PMID:
20870158
14.

Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.

Hirvonen J, Hietala J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, Någren K, Aalto S, Karlsson H.

J Psychopharmacol. 2011 Oct;25(10):1329-36. doi: 10.1177/0269881110376691. Epub 2010 Sep 9.

PMID:
20829308
15.

A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.

Narendran R, Mason NS, Laymon CM, Lopresti BJ, Velasquez ND, May MA, Kendro S, Martinez D, Mathis CA, Frankle WG.

J Pharmacol Exp Ther. 2010 May;333(2):533-9. doi: 10.1124/jpet.109.163501. Epub 2010 Jan 26.

16.

SIC, an intracerebral beta(+)-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with (11)C-raclopride.

Zimmer L, Hassoun W, Pain F, Bonnefoi F, Lanièce P, Mastrippolito R, Pinot L, Pujol JF, Leviel V.

J Nucl Med. 2002 Feb;43(2):227-33.

17.

Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.

Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA.

J Cereb Blood Flow Metab. 2012 Jan;32(1):127-36. doi: 10.1038/jcbfm.2011.115. Epub 2011 Aug 31.

18.

Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.

Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E.

Arch Neurol. 2004 Nov;61(11):1705-9.

PMID:
15534182
19.

[Image reconstruction and quantification in emission tomography].

Mix M, Eschner W.

Z Med Phys. 2006;16(1):19-30. Review. German.

PMID:
16696368

Supplemental Content

Support Center